WithdrawnNCT03762798
Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone
Device studyAges 18–99United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 99 years.
- Listed locations
- ClevelandSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 19, 2018
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- The Cleveland Clinic
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT03762798
- Official title
Show the full official title
Can The Bridge Facilitate Successful Transition From Medication-Assisted Treatment (MAT) With Low-dose Sublingual Buprenorphine to Oral Naltrexone in Patients With Extended Remission of Opiate Use Disorder
Recruitment & locations
WithdrawnCleveland
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is The Cleveland Clinic, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 99 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
